Bio-Gene Technology Limited, an Australian biotech firm, has joined forces with Envu, a global leader in environmental science, to advance the use of their novel mosquito control agent, Flavocide™. This collaboration aims to leverage Flavocide’s unique properties in the fight against mosquito-borne diseases, a significant global health challenge.
Vector-borne diseases, which include malaria, dengue fever, and Zika virus, account for over 17% of all infectious diseases and lead to more than 700,000 deaths annually. Malaria alone results in approximately 219 million cases worldwide and causes over 400,000 deaths each year, predominantly affecting children under five years old.
Envu, known for its innovative solutions in managing pests, weeds, and turf diseases, is dedicated to sustainable and nature-positive approaches. The company’s partnership with Bio-Gene aligns with its commitment to advancing effective, eco-friendly pest management strategies.
Flavocide is a nature-identical insecticide derived from Flavesone, a compound found in certain eucalyptus species. Bio-Gene has developed a proprietary method to synthesise this molecule, making it commercially viable. The new product is noted for its novel mode of action, which distinguishes it from existing insecticides and could potentially address the growing problem of insecticide resistance.
Tim Grogan, Managing Director and CEO of Bio-Gene highlighted the significance of this collaboration: “Partnering with Envu extends Flavocide’s potential to target major markets for professional pest management and public health globally. Envu’s expertise in developing and marketing sustainable pest control products is crucial for realising the full potential of our technology.”
Bernard Jacqmin, Senior Vice President and Head of Global Innovation at Envu, expressed enthusiasm about the partnership: “We are delighted to work with Bio-Gene to formulate and test Flavocide for mosquito control. Initial results are promising, and we are eager to see how this nature-derived compound can benefit both consumers and professionals in managing mosquito populations.”
The collaboration has already seen successful trials of various Flavocide formulations aimed at mosquito control. The next phase will involve further testing and evaluation to optimise the product for a range of professional applications. Both companies are exploring commercial opportunities and will announce any future development or licensing agreements as they progress.
Flavocide’s introduction could offer a significant advancement in mosquito management, providing a new tool to combat diseases that pose a severe threat to global public health. As insecticide resistance becomes increasingly problematic, innovative solutions like Flavocide are crucial for maintaining effective pest control and safeguarding communities worldwide.
Contributed by: Business Wire